pramipexole has been researched along with ketoprofen in 2 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (ketoprofen) | Trials (ketoprofen) | Recent Studies (post-2010) (ketoprofen) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 3,089 | 677 | 1,008 |
| 1,103 | 219 | 517 | 6 | 0 | 2 |
| Protein | Taxonomy | pramipexole (IC50) | ketoprofen (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | 0.5 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 1.1942 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.008 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.168 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 0.18 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 1.35 | |
| Interleukin-8 | Homo sapiens (human) | 0.02 | |
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | 0.034 | |
| C-X-C chemokine receptor type 2 | Homo sapiens (human) | 0.034 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
1 review(s) available for pramipexole and ketoprofen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for pramipexole and ketoprofen
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |